About Dr. Lu
Dai Lu, PhD, is an associate professor of pharmaceutical sciences at the Texas A&M Irma Lerma Rangel College of Pharmacy. His research interests include entry-level and advanced medicinal and organic chemistry, pharmacology of drugs for oncology, diabetes and neurodegenerative diseases.
Dr. Lu's research is engaged in the discovery of potential therapeutics for the treatment of cancer, neurodegenerative diseases and various disorders associated with the endocannabinoid system such as pain, drug-addiction and obesity. Other projects in the Lu lab include the synthesis of water-soluble analogs of natural products such as taxanes and cannabinoids; the synthesis of various pharmacologically important cannabinoid ligands including agonists, inverse agonists, and allosteric modulators; the synthesis of novel protein kinase inhibitors to regulate the Abelson kinases (ABLs) and cyclin dependent kinases (CDKs).
Dr. Lu received his Bachelor of Science in organic chemistry from Nankai University, Tianjin, China, Master of Science in medicinal chemistry from Peking Union Medical College, Chinese Academy of Medical Sciences in Beijing, China and his doctorate degree in pharmaceutical sciences and medicinal chemistry from the University of Connecticut.
Vital Record news coverage
Texas A&M researchers discover a new regulator of mitochondria in invasive cancer growth
How the powerhouse of the cell affects the spread of deadly cancers
November 23, 2016
Pharmacy researcher fights cancer, pain with new drug
August 13, 2013